Dow Down 0.58% Nasdaq Down 1.19%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
37.83 Up 0.32(0.85%) 2:50PM EDT - Nasdaq Real Time Price
Prev Close:37.51
Open:37.29
Bid:37.68 x 200
Ask:37.75 x 200
1y Target Est:39.08
Beta:0.93
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:37.25 - 38.10
52wk Range:20.02 - 42.50
Volume:282,677
Avg Vol (3m):797,139
Market Cap:2.75B
P/E (ttm):16.04
EPS (ttm):2.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MYGNUp 0.85%2.75B
ABTDown 0.48%65.23B

Key Statistics

Forward P/E (1 yr):16.99
P/S (ttm):3.51
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :1.93
Quarterly EPS Est (Sep-14) :0.41
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):1.26

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback